PubMed:25163405 / 0-668
Annnotations
PubMed_Structured_Abstracts
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 145-293 | BACKGROUND | denotes | Epinastine hydrochloride is a selective histamine H1 receptor antagonist that also inhibits IgE receptor-mediated histamine release from mast cells. |
| T2 | 305-571 | OBJECTIVE | denotes | To show the superiority of epinastine 0.05% ophthalmic solution (epinastine) to placebo ophthalmic solution (placebo) and noninferiority to olopatadine 0.1% ophthalmic solution (olopatadine) for cedar pollen antigen-induced ocular itching and conjunctival hyperemia. |
maxiaofeng52_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 69-83 | DP | denotes | conjunctivitis |
| T5 | 145-169 | CI | denotes | Epinastine hydrochloride |
| T6 | 12-36 | CI | denotes | epinastine hydrochloride |
| T7 | 332-342 | CI | denotes | epinastine |
| T9 | 370-380 | CI | denotes | epinastine |
| T14 | 385-392 | CI | denotes | placebo |
| T15 | 414-421 | CI | denotes | placebo |
| T19 | 445-456 | CI | denotes | olopatadine |
| T20 | 483-494 | CI | denotes | olopatadine |
wangzhuo19_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 370-380 | CI | denotes | epinastine |
| T13 | 12-36 | CI | denotes | epinastine hydrochloride |
| T14 | 332-342 | CI | denotes | epinastine |
| T19 | 145-169 | CI | denotes | Epinastine hydrochloride |
| T7 | 385-392 | CI | denotes | placebo |
| T8 | 414-421 | CI | denotes | placebo |
| T21 | 69-83 | DP | denotes | conjunctivitis |
| T25 | 445-456 | CI | denotes | olopatadine |
| T26 | 483-494 | CI | denotes | olopatadine |